{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=FMS", "query": { "condition": "FMS" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 445, "total_pages": 45, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=FMS&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-07-23T22:22:23.475Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00000428", "title": "Combining N-of-1 Trials to Assess Fibromyalgia Treatments", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Fibromyalgia" ], "interventions": [ { "name": "Amitriptyline", "type": "DRUG" }, { "name": "Amitriptyline plus Fluoxitine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Tufts Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 58, "start_date": "2000-09", "completion_date": "2004-03", "has_results": false, "last_update_posted_date": "2013-08-01", "last_synced_at": "2026-07-23T22:22:23.475Z", "location_count": 7, "location_summary": "Brockton, Massachusetts • Fall River, Massachusetts • Framingham, Massachusetts + 4 more", "locations": [ { "city": "Brockton", "state": "Massachusetts" }, { "city": "Fall River", "state": "Massachusetts" }, { "city": "Framingham", "state": "Massachusetts" }, { "city": "Melrose", "state": "Massachusetts" }, { "city": "Needham", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT00000428" }, { "nct_id": "NCT02829814", "title": "Repeat of: A Study to Evaluate Efficacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With Fibromyalgia", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Fibromyalgia", "Myofascial Pain Syndromes", "Muscular Diseases", "Nervous System Diseases", "Neuromuscular Diseases", "Rheumatic Diseases", "Musculoskeletal Diseases" ], "interventions": [ { "name": "TNX-102 SL Tablet, 2.8 mg", "type": "DRUG" }, { "name": "Placebo SL Tablet", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Tonix Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 51, "start_date": "2016-07-22", "completion_date": "2016-09-13", "has_results": true, "last_update_posted_date": "2025-02-25", "last_synced_at": "2026-07-23T22:22:23.475Z", "location_count": 32, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Oceanside, California + 28 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Oceanside", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Brandon", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02829814" }, { "nct_id": "NCT03840928", "title": "PatientSpot Formerly Known as ArthritisPower", "overall_status": "UNKNOWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Rheumatoid Arthritis", "Ankylosing Spondylitis", "Fibromyalgia", "Gout", "Crohn Disease", "Juvenile Idiopathic Arthritis", "Lupus Erythematosus", "Myositis", "Osteoarthritis", "Osteoporosis", "Psoriasis", "Psoriatic Arthritis", "Scleroderma", "Dermatomyositis", "Inflammatory Bowel Diseases", "Polymyositis", "Axial Spondyloarthritis", "Diffuse Idiopathic Skeletal Hyperostosis", "Polymyalgia Rheumatica", "Giant Cell Arteritis", "Temporal Arteritis", "Wegener", "Relapsing Polychondritis", "Undifferentiated Connective Tissue Disease", "Spinal Cord Injuries", "Alzheimer Disease", "Amyotrophic Lateral Sclerosis", "Ataxia", "Bell Palsy", "Brain Tumor", "Cerebral Aneurysm", "Epilepsy", "Guillain-Barre Syndrome", "Headache", "Head Injury", "Hydrocephalus", "Lumbar Disc Disease", "Meningitis", "Multiple Sclerosis", "Muscular Dystrophy", "Neurocutaneous Syndromes", "Parkinson Disease", "Stroke", "Cluster Headache", "Tension-Type Headache", "Chronic Obstructive Pulmonary Disease", "Asthma", "Lung Cancer", "Cystic Fibrosis", "Sleep Apnea", "Eczema", "Alopecia", "Chronic Inflammation", "Unstable Angina", "Heart Attack", "Heart Failure", "Arrythmia", "Valve Heart Disease", "High Blood Pressure", "Congenital Heart Disease", "Peripheral Arterial Disease", "Diabetes", "Chronic Liver Disease", "Obesity" ], "interventions": [], "intervention_types": [], "sponsor": "Global Healthy Living Foundation", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "19 Years", "maximum_age": null, "sex": "ALL", "summary": "19 Years and older" }, "enrollment_count": 40000, "start_date": "2015-04-01", "completion_date": "2025-03-01", "has_results": false, "last_update_posted_date": "2023-12-13", "last_synced_at": "2026-07-23T22:22:23.475Z", "location_count": 1, "location_summary": "Upper Nyack, New York", "locations": [ { "city": "Upper Nyack", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT03840928" }, { "nct_id": "NCT04862871", "title": "Enhancing Analgesia in Chronic Pain Through Exercise", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Pain", "Chronic Widespread Pain", "Fibromyalgia" ], "interventions": [ { "name": "Physical Activity - Pediatric Pain Rehabilitation Center", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Boston Children's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "10 Years", "maximum_age": "24 Years", "sex": "ALL", "summary": "10 Years to 24 Years" }, "enrollment_count": 30, "start_date": "2022-04-01", "completion_date": "2022-11", "has_results": false, "last_update_posted_date": "2022-05-11", "last_synced_at": "2026-07-23T22:22:23.475Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT04862871" }, { "nct_id": "NCT04599933", "title": "An Evaluation of the Efficacy and Safety of CSF-1 in the Temporary Correction of Presbyopia (NEAR-1)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Presbyopia" ], "interventions": [ { "name": "CSF-1", "type": "DRUG" }, { "name": "Vehicle", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Orasis Pharmaceuticals Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "45 Years", "maximum_age": "64 Years", "sex": "ALL", "summary": "45 Years to 64 Years" }, "enrollment_count": 309, "start_date": "2020-10-18", "completion_date": "2022-02-19", "has_results": true, "last_update_posted_date": "2024-04-04", "last_synced_at": "2026-07-23T22:22:23.475Z", "location_count": 17, "location_summary": "Sun City, Arizona • Glendale, California • Los Angeles, California + 14 more", "locations": [ { "city": "Sun City", "state": "Arizona" }, { "city": "Glendale", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Fort Myers", "state": "Florida" }, { "city": "Mt. Dora", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04599933" }, { "nct_id": "NCT05128162", "title": "Open-label Study to Assess the Safety and Efficacy of Psilocybin With Psychotherapy in Adult Participants With Fibromyalgia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Fibromyalgia" ], "interventions": [ { "name": "Psilocybin", "type": "DRUG" }, { "name": "Psychotherapy", "type": "BEHAVIORAL" } ], "intervention_types": [ "DRUG", "BEHAVIORAL" ], "sponsor": "Kevin Boehnke", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "25 Years", "maximum_age": "64 Years", "sex": "ALL", "summary": "25 Years to 64 Years" }, "enrollment_count": 17, "start_date": "2023-09-27", "completion_date": "2024-06-12", "has_results": true, "last_update_posted_date": "2025-04-16", "last_synced_at": "2026-07-23T22:22:23.475Z", "location_count": 1, "location_summary": "Ann Arbor, Michigan", "locations": [ { "city": "Ann Arbor", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT05128162" }, { "nct_id": "NCT02436096", "title": "A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Fibromyalgia", "Myofascial Pain Syndromes", "Muscular Diseases", "Musculoskeletal Diseases", "Nervous System Diseases", "Neuromuscular Diseases", "Rheumatic Diseases" ], "interventions": [ { "name": "TNX-102 SL Tablet, 2.8mg", "type": "DRUG" }, { "name": "Placebo SL Tablet", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Tonix Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 519, "start_date": "2015-04", "completion_date": "2016-09", "has_results": true, "last_update_posted_date": "2025-02-07", "last_synced_at": "2026-07-23T22:22:23.475Z", "location_count": 35, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Sacramento, California + 31 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Sacramento", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Brandon", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02436096" }, { "nct_id": "NCT03759522", "title": "Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Fibromyalgia", "Chronic Fatigue Syndrome", "Multiple Sclerosis", "Healthy" ], "interventions": [ { "name": "DPA-714 PET/MRI", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Alabama at Birmingham", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 120, "start_date": "2019-02-03", "completion_date": "2028-04", "has_results": false, "last_update_posted_date": "2026-06-02", "last_synced_at": "2026-07-23T22:22:23.475Z", "location_count": 1, "location_summary": "Birmingham, Alabama", "locations": [ { "city": "Birmingham", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT03759522" }, { "nct_id": "NCT01322425", "title": "Effect of Temperature on Pain and Brown Adipose Activity in Fibromyalgia", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Fibromyalgia", "Pain" ], "interventions": [], "intervention_types": [], "sponsor": "University of Minnesota", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "FEMALE", "summary": "18 Years to 50 Years · Female only" }, "enrollment_count": 24, "start_date": "2010-07", "completion_date": "2014-07", "has_results": false, "last_update_posted_date": "2014-08-20", "last_synced_at": "2026-07-23T22:22:23.475Z", "location_count": 1, "location_summary": "Minneapolis, Minnesota", "locations": [ { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT01322425" }, { "nct_id": "NCT07245303", "title": "Neural Mechanisms of Light Driven Analgesia", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Musculoskeletal Pain", "Fibromyalgia", "Healthy Controls Group - Age and Sex-matched" ], "interventions": [ { "name": "S-cone modulating visual stimulus", "type": "OTHER" }, { "name": "Equal Energy White Visual Stimulus", "type": "OTHER" }, { "name": "Green light visual stimulus (S-OFF)", "type": "OTHER" }, { "name": "Evoked Pressure Pain Stimulus", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of North Carolina, Chapel Hill", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 60, "start_date": "2026-02-24", "completion_date": "2030-01-31", "has_results": false, "last_update_posted_date": "2026-05-13", "last_synced_at": "2026-07-23T22:22:23.475Z", "location_count": 1, "location_summary": "Chapel Hill, North Carolina", "locations": [ { "city": "Chapel Hill", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT07245303" } ] }